NVIDIA (NVDA) and Lilly bring together a world-leading, multidisciplinary team of scientists, AI researchers and engineers to address the hardest problems in drug discovery. The co-innovation lab ...

Nvidia Corp (NASDAQ: NVDA) and Eli Lilly and Co (NYSE: LLY) are launching a lab designed to apply advanced artificial intelligence to drug development. The collaboration will combine Lilly's expertise ...

Nvidia Corp. is partnering with Eli Lilly and Co. to open a research lab that will use artificial intelligence to speed up drug discovery. The companies announced the collaboration today. They plan to ...

Eli Lilly and Nvidia will launch a co-innovation AI lab to accelerate drug discovery. The companies will jointly invest up to $1 billion over five years to support the lab, which is based in the Bay ...

Seeking Alpha's roundup of statements, announcements, and remarks that could impact the technology sector. Nvidia (NVDA) and Eli Lilly (LLY) said they're investing up to $1B over five years to develop ...

Nvidia and Eli Lilly are partnering to launch a co-innovation lab to use Nvidia's artificial-intelligence and robotics expertise for drug discovery. The companies said Monday they would invest up to ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The corporate giants will invest ...

Nvidia and Eli Lilly are partnering to launch a co-innovation lab to use Nvidia's artificial-intelligence and robotics expertise for drug discovery. The companies said Monday they would invest up to ...